期刊
DRUG RESISTANCE UPDATES
卷 8, 期 3, 页码 147-162出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.drup.2005.04.007
关键词
Candida; neonatal intensive care unit; antifungal therapy
资金
- NIAID NIH HHS [T32 AI 052080] Funding Source: Medline
- NICHD NIH HHS [HD044799] Funding Source: Medline
- PHS HHS [K08 A1061149-01] Funding Source: Medline
Advances in medical therapy have increased premature infant survival. A rise in Candida infections in neonatal intensive care units (NICUs) has followed. Once considered a contaminant, Candida is now recognized as a major cause of mortality and morbidity within these units. We will examine what is known about the epidemiology, risk factors and end-organ involvement of Candida infections with a focus on invasive disease. In addition, diagnostic alternatives to traditional blood culture, experience with antifungal agents for prophylaxis and therapeutic options, including newer antifungal agents, will be presented. (c) 2005 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据